US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India’s pharmaceutical sector. This sector is vital for affordable medicines and economic stability, with the US market representing 30% of Indian exports.
Related Posts
Gambhir’s call answered: Rohit, Pant lead India stars back to domestic cricket
Indian cricket veterans, including Sunil Gavaskar, Ravi Shastri, and Gautam Gambhir, stress the importance of Ranji Trophy participation to aid players like Rohit Sharma and […]